drugset / Trial / NCT02350634

18F-AV-1451 High Resolution Autopsy Study

NCT02350634

Phase 1 Completed 3 enrolled Avid Radiopharmaceuticals
NaSingle-groupOpen-labelDiagnostic

Summary

The study is designed to examine the relationship between imaging results detected on a 18F-AV-1451 PET scan and pathology found at autopsy within six months of imaging.

Timeline

Start
2016-11-26
Primary completion
2017-06-16
Completion
2017-06-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Flortaucipir F18 Diagnostic / imaging agent 370 mbq Intravenous

Indications